March 14, 2016 |
Study Launch at 37 clinical site locations with 14 study drugs |
March 2016 |
1st participant registered (consented) |
April 2016 |
1st participant enrolled, 2 additional drugs added for total of 16 study drugs |
May 2016 |
Additional drug added for total of 17 study drugs |
August 2016 |
100th participant registered |
November 2016 |
100e participant enrolled |
April 2017 |
33 clinical sites added, for a total of 70 locations |
June 2017 |
500th participant registered |
August 2017 |
Additional therapy added for 19 study drugs |
September 2017 |
1st cohort reaches Stage I |
November 2017 |
500th participant enrolled |
December 2017 |
43 clinical sites added, for a total of 113 locations |
February 2018 |
1000th participant registered |
March 2018 |
10th cohort reaches Stage I |